148 related articles for article (PubMed ID: 34404110)
1. Identification of seven psychedelic 2,5-dimethoxy-phenylethyl-amine-based designer drugs via benchtop
Araneda JF; Baumgarte M; Lange M; Maier AFG; Riegel SD
Magn Reson Chem; 2023 Feb; 61(2):66-72. PubMed ID: 34404110
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of 2,5-dimethoxy-3,4-dimethyl-β-phenethylamine (2C-G)--a new designer drug.
Zuba D; Sekuła K
Drug Test Anal; 2013 Jul; 5(7):549-59. PubMed ID: 22927304
[TBL] [Abstract][Full Text] [Related]
3. Designer psychostimulants in urine by liquid chromatography-tandem mass spectrometry.
Kerrigan S; Mott A; Jatzlau B; Ortiz F; Perrella L; Martin S; Bryand K
J Forensic Sci; 2014 Jan; 59(1):175-83. PubMed ID: 24313279
[TBL] [Abstract][Full Text] [Related]
4. Analytical characterization of three hallucinogenic N-(2-methoxy)benzyl derivatives of the 2C-series of phenethylamine drugs.
Zuba D; Sekuła K
Drug Test Anal; 2013 Aug; 5(8):634-45. PubMed ID: 22936468
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of commercial enzyme-linked immunosorbent assays to identify psychedelic phenethylamines.
Kerrigan S; Mellon MB; Banuelos S; Arndt C
J Anal Toxicol; 2011 Sep; 35(7):444-51. PubMed ID: 21871153
[TBL] [Abstract][Full Text] [Related]
6. Benchtop nuclear magnetic resonance spectroscopy in forensic chemistry.
Draper SL; McCarney ER
Magn Reson Chem; 2023 Feb; 61(2):106-129. PubMed ID: 34286862
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous detection of ten psychedelic phenethylamines in urine by gas chromatography-mass spectrometry.
Kerrigan S; Banuelos S; Perrella L; Hardy B
J Anal Toxicol; 2011 Sep; 35(7):459-69. PubMed ID: 21871155
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the designer drug bk-2C-B (2-amino-1-(bromo-dimethoxyphenyl)ethan-1-one) by gas chromatography/mass spectrometry without and with derivatization with 2,2,2-trichloroethyl chloroformate, liquid chromatography/high-resolution mass spectrometry, and nuclear magnetic resonance.
Frison G; Odoardi S; Frasson S; Sciarrone R; Ortar G; Romolo FS; Strano Rossi S
Rapid Commun Mass Spectrom; 2015 Jul; 29(13):1196-204. PubMed ID: 26395784
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of 2,5-dimethoxy-4-nitro-β-phenethylamine (2C-N)--a new member of 2C-series of designer drug.
Zuba D; Sekuła K; Buczek A
Forensic Sci Int; 2012 Oct; 222(1-3):298-305. PubMed ID: 22854016
[TBL] [Abstract][Full Text] [Related]
10. Prodrugs of New Psychoactive Substances (NPS): A New Challenge.
Elliott SP; Holdbrook T; Brandt SD
J Forensic Sci; 2020 May; 65(3):913-920. PubMed ID: 31943218
[TBL] [Abstract][Full Text] [Related]
11. High-field and benchtop NMR spectroscopy for the characterization of new psychoactive substances.
Castaing-Cordier T; Ladroue V; Besacier F; Bulete A; Jacquemin D; Giraudeau P; Farjon J
Forensic Sci Int; 2021 Apr; 321():110718. PubMed ID: 33601154
[TBL] [Abstract][Full Text] [Related]
12. Phenethylamine-derived new psychoactive substances 2C-E-FLY, 2C-EF-FLY, and 2C-T-7-FLY: Investigations on their metabolic fate including isoenzyme activities and their toxicological detectability in urine screenings.
Wagmann L; Hempel N; Richter LHJ; Brandt SD; Stratford A; Meyer MR
Drug Test Anal; 2019 Oct; 11(10):1507-1521. PubMed ID: 31299701
[TBL] [Abstract][Full Text] [Related]
13. Screening of "spice" herbal mixtures: From high-field to low-field proton NMR.
Assemat G; Dubocq F; Balayssac S; Lamoureux C; Malet-Martino M; Gilard V
Forensic Sci Int; 2017 Oct; 279():88-95. PubMed ID: 28854352
[TBL] [Abstract][Full Text] [Related]
14. Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines - an update comprising adinazolam, cloniprazepam, fonazepam, 3-hydroxyphenazepam, metizolam and nitrazolam.
Moosmann B; Bisel P; Franz F; Huppertz LM; Auwärter V
J Mass Spectrom; 2016 Nov; 51(11):1080-1089. PubMed ID: 27535017
[TBL] [Abstract][Full Text] [Related]
15. Test purchase, identification and synthesis of 2-amino-1-(4-bromo-2, 5-dimethoxyphenyl)ethan-1-one (bk-2C-B).
Power JD; Kavanagh P; O'Brien J; Barry M; Twamley B; Talbot B; Dowling G; Brandt SD
Drug Test Anal; 2015 Jun; 7(6):512-8. PubMed ID: 25078895
[TBL] [Abstract][Full Text] [Related]
16. Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD).
Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Dowling G; Wallach J; Halberstadt AL
Drug Test Anal; 2019 Aug; 11(8):1122-1133. PubMed ID: 31083768
[TBL] [Abstract][Full Text] [Related]
17. A new trend in drugs-of-abuse; the 2C-series of phenethylamine designer drugs.
de Boer D; Bosman I
Pharm World Sci; 2004 Apr; 26(2):110-3. PubMed ID: 15085947
[TBL] [Abstract][Full Text] [Related]
18. 2C-B: a new psychoactive phenylethylamine recently discovered in Ecstasy tablets sold on the Swiss black market.
Giroud C; Augsburger M; Rivier L; Mangin P; Sadeghipour F; Varesio E; Veuthey JL; Kamalaprija P
J Anal Toxicol; 1998 Sep; 22(5):345-54. PubMed ID: 9737327
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of fentanyl analogues by low-field NMR spectroscopy.
Duffy J; Urbas A; Niemitz M; Lippa K; Marginean I
Anal Chim Acta; 2019 Feb; 1049():161-169. PubMed ID: 30612647
[TBL] [Abstract][Full Text] [Related]
20. Quantification of mixtures of analogues of illicit substances by benchtop NMR spectroscopy.
Lee Y; Matviychuk Y; Bogun B; Johnson CS; Holland DJ
J Magn Reson; 2022 Feb; 335():107138. PubMed ID: 35042173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
